{{Multiple issues|
{{one source|date=August 2014}}
{{refimprove|date=August 2014}}
}}

{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 408927686
| IUPAC_name = 5-[3,5-Dimethoxy-4-(2-methoxyethoxy)benzyl]pyrimidine-2,4-diamine
| image = Tetroxoprim.svg

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 53808-87-0
| ATC_prefix = J01
| ATC_suffix = EE06
| ATC_supplemental = (with [[sulfadiazine]])
| PubChem = 65450
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = 5R6712AY0K
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D06097
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 32039
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID      = 58910

<!--Chemical data-->
| chemical_formula =  
| C=16 | H=22 | N=4 | O=4 
| molecular_weight = 334.70 g/mol
| smiles = COCCOC1=C(C=C(C=C1OC)CC2=CN=C(N=C2N)N)OC
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI          = 1S/C16H22N4O4/c1-21-4-5-24-14-12(22-2)7-10(8-13(14)23-3)6-11-9-19-16(18)20-15(11)17/h7-9H,4-6H2,1-3H3,(H4,17,18,19,20)
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey       = WSWJIZXMAUYHOE-UHFFFAOYSA-N
}}

'''Tetroxoprim''' ([[International Nonproprietary Name|INN]]) is a derivative of [[trimethoprim]]. It was first described in 1979.<ref>{{cite journal |vauthors=Aschhoff HS, Vergin H |title=Tetroxoprim—a new inhibitor of bacterial dihydrofolate reductase |journal=J Antimicrob Chemother |volume=5 |issue=B |pages=19–25 |date=November 1979 |pmid=43863 |doi= 10.1093/jac/5.supplement_b.19|url=}}</ref>

==References==
{{Reflist}}

{{Sulfonamides and trimethoprim}}

[[Category:Bacterial dihydrofolate reductase inhibitors]]
[[Category:Pyrimidines]]
[[Category:Phenol ethers]]


{{antibiotic-stub}}